Leucocyte activation by collagen-stimulated platelets in whole blood.
T Bengtsson, M Grenegård
Index: Scand. J. Clin. Lab. Invest. 62(6) , 451-61, (2002)
Full Text: HTML
Abstract
Interaction between vascular cells plays an important role in the initial phases of the inflammatory process, but the mechanisms responsible for cell-cell communication are not fully understood. In this study, activation of leucocytes and platelets in heparinized whole blood was assessed using lumi-aggregometry. This technique enables simultaneous measurement of aggregation and oxygen radical production by monitoring impedance and luminol-amplified chemiluminescence (CL), respectively. Collagen induced aggregation and CL, depending on dose, and markedly enhanced subsequent aggregation and CL-response triggered by the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (fMet-Leu-Phe). Collagen stimulation of whole blood down- and upregulated the expression of L-selectin and CD11b, respectively. Monoclonal antibodies against sialyl LewisX and P-selectin caused a pronounced inhibition of the oxidative burst, triggered by collagen itself or by a combination of collagen and fMet-Leu-Phe. Furthermore, the Arg-Gly-Asp-Ser(RGDS)-peptide effectively inhibited collagen-triggered aggregation and CL, and the subsequent enhancement of the fMet-Leu-Phe-induced responses. This suggests that fibrinogen plays a part in linking platelet GpIIb/IIIa with CD11b on the leucocyte surface. However, neither anti-CD11b nor the PI-peptide (containing the gamma-chain motif in fibrinogen that interacts with CD11b) counteracted the stimulatory effects of activated platelets on leucocyte functions. The selectin- and integrin-antagonizing substances were ineffective on the CL-responses induced by fMet-Leu-Phe itself. This study suggests that, through selectin- and integrin-dependent interaction, activated platelets potentiate leucocyte aggregation and oxygen radical production, which might be important for the outcome of inflammatory reactions.
Related Compounds
Related Articles:
1998-02-01
[Antimicrob. Agents Chemother. 42(2) , 348-51, (1998)]
2004-01-28
[J. Am. Chem. Soc. 126(3) , 948-58, (2004)]
1989-02-01
[Biochem. J. 257(3) , 633-7, (1989)]
1992-11-01
[J. Immunol. 149(9) , 3059-65, (1992)]
1991-03-01
[Can. J. Physiol. Pharmacol. 69(3) , 419-25, (1991)]